Atara Biotherapeutics Market Sentiment

Atara Biotherapeutics Inc

ATRANASDAQ

Trade with Public

$9.69

가까이에: Sep 21, 5:00 PM EST

$9.69

N/A

시간외: Sep 18, 4:01 PM EST

개요 뉴스 실적 전망 이벤트 목표가 재무심리지분 현황 비교 주식 보고서

Atara Biotherapeutics Market Sentiment

Market sentiment signals for Atara Biotherapeutics (ATRA): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▲ 5.8% short float

Options Flow— N/A

Insider Activity▲ Net Buyer (30d)

Analyst Consensus

Buy

9 analysts

Options Flow (P/C)

—

Avg Consensus PT

$22

+131.4%

Highest Price Target

$58

+493.4%

Stifel

Lowest Price Target

$10

+3.2%

Freedom Broker

Short Interest

5.8%

Declining — Bullish

Insider Activity (30d)

Net Buyer

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
May 18, 2026	Freedom Broker	Ilya Zubkov—	+3.2%	$4 → $10	Upgrade	Sell→Hold
May 8, 2026	Canaccord Genuity	John Newman—	+34.2%	$6 → $13	Upgrade	Hold→Buy
Jan 21, 2026	Freedom Broker	Ilya Zubkov—	-58.7%	$16 → $4	Downgrade	Buy→Sell
Jan 13, 2026	Canaccord Genuity	John Newman—	-38.1%	$25 → $6	Downgrade	Buy→Hold
Dec 19, 2025	Canaccord Genuity	John Newman—	+158.0%	$17 → $25	Maintained	Buy
Jul 28, 2025	Freedom Broker	Ilya Zubkov—	+65.1%	$13 → $16	Maintained	Sell
May 23, 2025	Freedom Broker	Ilya Zubkov—	+34.2%	$11 → $13	Maintained	Sell
Mar 13, 2025	Freedom Broker	Ilya Zubkov—	+13.5%	$13 → $11	Maintained	Sell
Mar 11, 2025	Canaccord Genuity	John Newman—	+75.4%	$17 → $17	Maintained	Buy
Jan 28, 2025	HC Wainwright & Co.	Robert Burns—	—	—	Maintained	Neutral
Jan 22, 2025	HC Wainwright & Co.	Robert Burns—	—	—	Maintained	Neutral
Jan 17, 2025	Canaccord Genuity	John Newman—	+75.4%	$21 → $17	Maintained	Buy
Dec 20, 2024	Rodman & Renshaw	Tony Butler—	+158.0%	$25	Initiate	Buy
Nov 13, 2024	Canaccord Genuity	John Newman—	+116.7%	$13 → $21	Maintained	Buy
Aug 21, 2024	HC Wainwright & Co.	Robert Burns—	—	—	Maintained	Neutral
Aug 16, 2024	Mizuho	Salim Syed—	+85.8%	$25 → $18	Upgrade	Neutral→Outperform
Aug 13, 2024	Canaccord Genuity	John Newman—	+34.2%	$13 → $13	Maintained	Buy
Jul 17, 2024	Goldman Sachs	Tommie Reerink—	+13.5%	$13 → $11	Maintained	Sell
May 22, 2024	HC Wainwright & Co.	Robert Burns—	—	—	Maintained	Neutral
Apr 1, 2024	Stifel	Benjamin Burnett—	-76.3%	$5 → $2	Maintained	Hold
Nov 10, 2023	Goldman Sachs	Tommie Reerink—	-94.8%	$3 → $1	Maintained	Sell
Nov 9, 2023	Evercore ISI Group	Michael DiFiore—	—	—	Downgrade	Outperform→In-Line
Nov 9, 2023	HC Wainwright & Co.	Robert Burns—	—	—	Downgrade	Buy→Neutral
Nov 9, 2023	Mizuho	Salim Syed—	-89.7%	$31 → $1	Downgrade	Buy→Neutral
Sep 26, 2023	HC Wainwright & Co.	——	+189.0%	$28	Maintained	Buy